Ultrasound examination of the salivary glands in Sjogren’s disease

Por A. V. Torgashina
Publicado em 2021-09-01

Relationship of T regulatory cells content, activity and serum autoantibodies level in patients with systemic lupus erythematosus receiving rituximab

Por A V Torgashina
Publicado em 2009-04-01

Efficacy of rituximab for glandular Sjö gren's disease according to international clinical trials

Por A. V. Torgashina
Publicado em 2020-03-01

Differential diagnosis of bacterial sialadenitis in a rheumatologist's practice: a case report

Por A. V. Torgashina
Publicado em 2019-03-01

Specific features of regulatory T cells in patients with systemic lupus erythematosus

Por A. V. Torgashina, S. К. Solovyev
Publicado em 2018-12-01

The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review

Por A V Torgashina, V I Vasilyev
Publicado em 2018-05-01

Ozone therapy: underestimated opportunities in the treatment of large joint diseases

Por A. N. Torgashin, S. S. Rodionova, A. V. Torgashina
Publicado em 2019-09-01

The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: and is that so great?

Por E. V. Sokol, M. V. Cherkasova, A. V. Torgashina
Publicado em 2019-03-01

T-regulatory cells in systemic lupus erythematosus and rheumatoid arthritis

Por A V Torgashina, S Y Biykovskaya, S K Soloviev, E L Nasonov
Publicado em 2009-06-01

Diseases with major salivary glands enlargement and orbits, nose and paranasal sinuses lesions in the practice of a rheumatologist

Por E. V. Sokol, A. V. Torgashina, B. D. Chaltsev, Yu. I. Khvan, O. A. Golovina
Publicado em 2021-12-01

RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP

Por M. E. Tsanyan, S. K. Soloviev, A. V. Torgashina, E. N. Aleksandrova, S. G. Radenska-Lopovok, E. V. Nikolaeva, E. L. Nasonov
Publicado em 2014-06-01

Comparative characteristics of the clinical and laboratory features of the primary Sjogren’s syndrome associated with anticentromere antibodies and the “classic” subtype of the dis...

Por B. D. Chaltsev, V. I. Vasiliev, S. G. Palshina, A. V. Torgashina, E. V. Sokol, Yu. I. Khvan, E. B. Rodionova, T. N. Safonova
Publicado em 2021-05-01

Treatment of aseptic necrosis of the femoral head. Clinical guidelines

Por A. N. Torgashin, S. S. Rodionova, A. A. Shumsky, M. A. Makarov, A. V. Torgashina, I. F. Akhtyamov, A. N. Kovalenko, N. V. Zagorodniy, S. P. Mironov
Publicado em 2021-01-01

Autoimmune liver damage in patients with primary Sjogren's syndrome associated with anticentromeric antibodies

Por B. D. Chalcev, V. I. Vasiliev, S. G. Palshina, A. V. Torgashina, E. V. Sokol, J. I. Khvan, E. B. Rodionova, T. N. Safonova, T. P. Nekrasova
Publicado em 2021-06-01

CLINICAL AND LABORATORY FEATURES OF ANTICENTROMERE ANTIBODY-POSITIVE SJö GREN’S SYNDROME

Por B. D. Chaltsev, V. I. Vasilyev, S. G. Palshina, A. V. Torgashina, E. V. Sokol, Yu. I. Khvan, T. N. Safonova, E. V. Rodionova, I. V. Gaiduk, L. L. Borozdkin
Publicado em 2019-09-01

Characteristics of clinical, laboratory, and immunological manifestations in patients with anticentromere antibody-associated Sjögren's disease

Por B. D. Chaltsev, V. I. Vasilyev, S. G. Palshina, A. V. Torgashina, E. V. Sokol, Yu. I. Khvan, E. B. Rodionova, T. N. Safonova, S. V. Lapin, O. Yu. Tkachenko, A. V. Mazing
Publicado em 2020-11-01

Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review

Por E. L. Nasonov, B. S. Belov, A. M. Lila, E. S. Aronova, G. I. Gridneva, A. V. Kudryavtseva, E. V. Sokol, A. V. Torgashina, I. B. Vinogradova, D. I. Abdulganieva, A. Yu. Zimenko
Publicado em 2021-12-01